Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Iqvia Holdings Inc.
  6. Company
    IQV   US46266C1053

IQVIA HOLDINGS INC.

(IQV)
  Report
Delayed Nyse  -  04:03 2022-07-01 pm EDT
215.05 USD   -0.89%
06/30Pharmaxis Names New Chief Medical Officer
MT
06/24IQVIA HOLDINGS INC.(NYSE : IQV) dropped from Russell Midcap Value Index
CI
06/24IQVIA HOLDINGS INC.(NYSE : IQV) dropped from Russell 1000 Value Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Iqvia Holdings Inc.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:

- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;

- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;

- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.

Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).

Number of employees : 79 000 people.
Sales per Business
20202021Delta
Research & Development Solutions5 760.0050.7%7 556.0054.5% +31.18%
Technology & Analytics Solutions4 858.0042.8%5 534.0039.9% +13.92%
Contract Sales & Medical Solutions741.006.5%784.005.7% +5.8%
USD in Million
Sales per region
20202021Delta
United States3 975.6535%4 717.1634% +18.65%
Europe and Africa2 559.1022.5%4 357.0031.4% +70.26%
Asia-Pacific2 245.0019.8%2 669.0019.2% +18.89%
Americas1 443.3512.7%2 130.8415.4% +47.63%
USD in Million
Managers
Name Title Age Since
Ari Bousbib Chairman, President & Chief Executive Officer 60 2016
Ronald Bruehlman Chief Financial Officer & Executive Vice President 60 2020
Karl Guenault Chief Information Officer & Senior Vice President - 2017
Jeffrey Spaeder Chief Medical & Scientific Officer - -
Costa Panagos President-Research & Development Solutions - 2022
Jim Berkshire Senior Vice President-Business Operations 48 2017
Nick Childs SVP-Investor Relations & Corporate Communications - 2021
Emmanuel N. Korakis Treasurer, Chief Accounting Officer & Controller 43 -
Eric M. Sherbet Secretary, Executive VP & General Counsel 56 -
Kevin Knightly President-Technology & Commercial Solutions 60 2016
Members of the board
Name Title Age Since
Ari Bousbib Chairman, President & Chief Executive Officer 60 2016
John Leonard Lead Independent Director 63 2015
John P. Connaughton Independent Director 55 2016
Ronald Rittenmeyer Independent Director 73 2016
Todd Benjamin Sisitsky Independent Director 49 2016
John G. Danhakl Independent Director 64 2016
James A. Fasano Independent Director 51 2016
Colleen A. Goggins Independent Director 66 2017
Carol J. Burt Independent Director 63 2019
Leslie Wims Morris Independent Director 50 2022
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 256,179,035 187,787,305 73.3% 66,900,000 26.1% 73.3%
Shareholders
NameEquities%
The Vanguard Group, Inc. 20,464,184 10.8%
SSgA Funds Management, Inc. 8,306,345 4.39%
AllianceBernstein LP 4,219,080 2.23%
BlackRock Fund Advisors 4,000,845 2.11%
3i Investments Plc 3,958,501 2.09%
Geode Capital Management LLC 3,604,991 1.90%
Fidelity Management & Research Co. LLC 3,578,421 1.89%
Leonard Green & Partners LP 3,376,167 1.78%
Longview Partners LLP 3,140,613 1.66%
Farallon Capital Management LLC 3,117,582 1.65%
Markets and indexes
- Main Market
- S&P 500 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  IQV.N
- Datastream Code :  
Company contact information
Iqvia Holdings Inc.
83 Road Wooster Heights
CT 06810 Danbury, Connecticut

Phone : +1 203 448 4600
Fax :
web site : https://www.iqvia.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Iqvia Holdings Inc.
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
IQVIA HOLDINGS INC.-23.78%40 704
MODERNA, INC.-40.96%56 820
LONZA GROUP AG-33.17%39 547
SEAGEN INC.16.50%32 570
CELLTRION, INC.-9.60%19 048
ALNYLAM PHARMACEUTICALS, INC.-13.99%17 621
ICON PUBLIC LIMITED COMPANY-31.32%17 616
PHARMARON BEIJING CO., LTD.1.66%16 084
HANGZHOU TIGERMED CONSULTING CO., LTD-9.78%14 097
BIO-TECHNE CORPORATION-31.73%13 600
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.-41.92%10 871
QIAGEN N.V.-13.91%10 736
UNITED THERAPEUTICS CORPORATION10.14%10 674
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.5.44%10 352
GENSCRIPT BIOTECH CORPORATION-17.54%7 656
SYNEOS HEALTH, INC.-30.30%7 353
JOINN LABORATORIES(CHINA)CO.,LTD.-0.29%5 963
AZENTA, INC.-31.27%5 367
IONIS PHARMACEUTICALS, INC.25.07%5 249
BACHEM HOLDING AG-49.58%5 125
ALKERMES PLC31.26%4 890
Connections : Iqvia Holdings Inc.